Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes.
Related Posts
Top F.D.A. Official Overrode Scientists on Covid Shots
Records show that a top U.S. regulator rejected the recommendations of agency experts and limited the use of Covid vaccines.
Bellevue Hospital Rushes Patients Into Weight-Loss Surgery
Early one morning in February, a guard clanged on the door of David Mustiga’s jail cell on Rikers Island. Soon,…
Medical Care for Transgender Youth: ‘The Protocol’ Podcast
Coming June 5: A six-part podcast exploring the origins of medical treatment for transgender young people, and how the care…
